BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33147666)

  • 1. Tumoral melanosis after immunotherapy with pembrolizumab - a response sign mimicking melanoma.
    Relvas M; Alves F; Mariano A; Cardoso J; Coutinho I
    Dermatol Online J; 2020 Oct; 26(10):. PubMed ID: 33147666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumoral Melanosis in the Setting of Targeted Immunotherapy for Metastatic Melanoma-A Single Institutional Experience and Literature Review.
    Jurgens A; Guru S; Guo R; Brewer J; Bridges A; Jakub J; Comfere N
    Am J Dermatopathol; 2021 Jan; 43(1):9-14. PubMed ID: 32149829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumoral Melanosis Associated with Pembrolizumab-Treated Metastatic Melanoma.
    Bari O; Cohen PR
    Cureus; 2017 Feb; 9(2):e1026. PubMed ID: 28348944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive tumoral melanosis associated with ipilimumab-treated melanoma.
    Staser K; Chen D; Solus J; Rosman IS; Schaffer A; Cornelius L; Linette GP; Fields RC
    Br J Dermatol; 2016 Aug; 175(2):391-3. PubMed ID: 26877232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulomatous Tumoral Melanosis Associated With Pembrolizumab Therapy: A Mimicker of Disease Progression in Metastatic Melanoma.
    Woodbeck R; Metelitsa AI; Naert KA
    Am J Dermatopathol; 2018 Jul; 40(7):523-526. PubMed ID: 29924748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node melanosis from a primary cutaneous lesion combining a nodular (tumoral) melanosis and a congenital dermal melanocytic nevus.
    Rongioletti F; Pavesi A; Carli C; Parodi A; Fiocca R
    Am J Dermatopathol; 2012 Aug; 34(6):653-7. PubMed ID: 22456514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic Melanoma Negative for 5 Melanocytic Markers, Complete Regressed Primary Cutaneous Melanoma, and Melanoma-Associated Leukoderma in the Same Patient.
    Ramos-Rodríguez C; García-Arpa M; Relea-Calatayud MF; González-López L; Romero-Aguilera G
    Am J Dermatopathol; 2020 Dec; 42(12):956-960. PubMed ID: 32809978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumoral melanosis involving the sentinel lymph nodes: a case report.
    Satzger I; Völker B; Kapp A; Gutzmer R
    J Cutan Pathol; 2007 Mar; 34(3):284-6. PubMed ID: 17302615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanosis in association with metastatic malignant melanoma: report of a case and a unifying concept of pathogenesis.
    Murray C; D'Intino Y; MacCormick R; Nassar B; Walsh N
    Am J Dermatopathol; 1999 Feb; 21(1):28-30. PubMed ID: 10027522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumoral melanosis as a manifestation of a completely regressed primary melanoma with metastases.
    Ng SH; Chave TA
    Br J Dermatol; 2006 Sep; 155(3):627-8. PubMed ID: 16911294
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymph node melanosis in a patient with metastatic melanoma of unknown primary.
    Malafronte P; Sorrells T
    Arch Pathol Lab Med; 2009 Aug; 133(8):1332-4. PubMed ID: 19653733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic melanoma with features of blue nevus and tumoral melanosis identified during pembrolizumab therapy.
    Helm MF; Bax MJ; Bogner PN; Chung CG
    JAAD Case Rep; 2017 Mar; 3(2):135-137. PubMed ID: 28367487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumoral Melanosis Nine Years After Wide Local Excision of a Thin Melanoma.
    Kieran I; Mowatt D; Gajanan K; Shenjere P; Kosutic D
    Dermatol Surg; 2016 Jun; 42(6):779-80. PubMed ID: 27158884
    [No Abstract]   [Full Text] [Related]  

  • 14. Diffuse melanosis after chemotherapy-induced tumor lysis syndrome in a patient with metastatic melanoma.
    Busam KJ; Wolchok J; Jungbluth AA; Chapman P
    J Cutan Pathol; 2004 Mar; 31(3):274-80. PubMed ID: 14984582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse cutaneous melanosis: rare complication of metastatic melanoma.
    Amaral ACVD; Diniz LM; Lucas EA; Capeli RLA
    An Bras Dermatol; 2017; 92(5 Suppl 1):62-64. PubMed ID: 29267449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous tumoural melanosis: a presentation of complete regression of cutaneous melanoma.
    Ching D; Amini E; Harvey NT; Wood BA; Mesbah Ardakani N
    Pathology; 2019 Jun; 51(4):399-404. PubMed ID: 31023480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metastasis in a patient with melanoma receiving Pembrolizumab therapy: A case report and review of the literature.
    Song JC; Ding XL; Sun XH; Safi M; Tian J
    Medicine (Baltimore); 2017 Dec; 96(50):e9278. PubMed ID: 29390382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case of metastatic melanoma in an epitrochlear lymph node arising in a pregnant woman.
    Yoshida Y; Takahashi A; Koga M; Koga K; Kubota Y; Nakayama J
    J Dermatol; 2007 Jan; 34(1):48-51. PubMed ID: 17204101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cutaneous regressing/regressed malignant melanoma: a clinicopathologic analysis of 8 cases].
    Shen XX; Kong YY; Dai B; Cai X; Wang LW; Kong JC
    Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):675-8. PubMed ID: 24433730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tattoo Pigment within Regional Lymph Nodes Mimicking Cutaneous Melanoma Metastasis.
    Dujmović A; Jurišić N; Mance M; Bulić K; Vrbanović Mijatović V; Mijatović D
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):47-48. PubMed ID: 32650854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.